";s:4:"text";s:5424:" Int J Dermatol 37 (1998): 410-54. del Palacio Hernandez A, Lopez Gomez S, Gonzalez Lastra F, Moreno Palancar P, Iglesias Diez L "A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris."
Grunwald MH, Amichai B "Thrombocytopenia associated with oral terbinafine." O 03.
Paredes AH, Lewis JH "Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection." Stricker BHC, Vanriemsdijk MM, Sturkenboom MCJM, Ottervanger JP "Taste loss to terbinafine: a case-control study of potential risk factors." Pamelor (nortriptyline)." Itching 7. Clin Exp Dermatol 20 (1995): 247-819.
Side effects requiring immediate medical attention.
BMJ 307 (1993): 267. If experienced, these tend to have a Severe expression 1. Indigestion 5. J Am Acad Dermatol 38 (1998): 765-733. Available for Android and iOS devices. Arch Dermatol 131 (1995): 937-426. Rossetti G, Livio F, Roulet E, Hofer MF "Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine." Ann Pharmacother 41 (2007): 880-427.
She had initiated therapy 14 days before onset of the generalized rash, for a nonspecific squamous plaque of the trunk. Br J Dermatol 140 (1999): 1196-734. Kovacs MJ, Alshammari S, Guenther L, Bourcier M "Neutropenia and pancytopenia associated with oral terbinafine." He was given 250 mg once daily over a 12-week period for dermatophyte toenail onychomycosis.
Beltraminelli HS, Lerch M, Arnold A, Bircher AJ, Haeusermann P "Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature." He presented with a symmetrical maculopapular eruption on both lower anterior legs. Vomiting has also been reported during postmarketing experience with the tablets.An 81-year-old male who had been treated with topical antifungal agents for An 80-year-old female experienced DRESS secondary to severe sialadenitis coincident with this drug. Br J Dermatol 152 (2005): 780-337. J Am Acad Dermatol 30 (1994): 50920. Juhlin L "Loss of taste and terbinafine." O 030.
Available for Android and iOS devices.We comply with the HONcode standard for trustworthy health information - Br J Clin Pharmacol 42 (1996): 313-89. Shapiro M, Li LJ, Miller J "Terbinafine-induced neutropenia." Rzany B, Mockenhaupt M, Gehring W, Schopf E "Stevens-Johnson syndrome after terbinafine therapy." Blood tests may be needed to check for any unwanted effects. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Beutler M, Hartmann K, Kuhn M, Gartmann J "Taste disorders and terbinafine."
Br J Cancer 138 (1998): 709-1017. Liver function studies began to normalize 6 weeks after this drug was discontinued.Pyrexia has been reported with the oral granules; it has also been reported during postmarketing experience with the tablets.Malaise and fatigue have also been reported during postmarketing experience.Changes in the ocular lens and retina have been reported; however, the clinical significance is unknown.Dyschromatopsia, whereby the patient reported a greenish hue in her vision, and photopsia have occurred in a patient after 3 weeks of therapy. Lancet 340 (1992): 72810. Balfour JA, Faulds D "Terbinafine. Along with its needed effects, nortriptyline (the active ingredient contained in Some side effects of nortriptyline may occur that usually Check with your health care professional if any of the following side effects 1. J Am Acad Dermatol 44 (2001): 925-3116. Gupta AK, Kopstein JB, Shear NH "Hypersensitivity reaction to terbinafine." Intense Abdominal Pain 6. This problem resolved within 1 week of discontinuing the drug.Agranulocytosis, thrombocytopenia, anemia, and pancytopenia have also been reported during postmarketing experience.1.
Cerner Multum, Inc. "UK Summary of Product Characteristics."
Cerner Multum, Inc. "Australian Product Information." Carstens J, Wendelboe P, Sogaard H, Thestrup-Pedersen K "Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine." Within 2 days, the rash generalized with facial involvement. A Skin Rash 2.
Topical therapy was started with 0.5% A 68-year-old male experienced acute generalized exanthematous pustulosis coincident with this drug. Isolated cases of prolonged hypogeusia have been reported.Taste disturbance (including taste loss), paresthesia, hypoesthesia, Vomiting, upper abdominal pain, and toothache have been reported with the oral granules. "Product Information. The taste alteration has been rarely accompanied by a discoloration of the tongue and/or a disturbance in the sense of smell.Hypogeusia (including ageusia) usually recovered within several weeks after this drug was stopped.
"Itracanazole, terbinafine possibly linked to liver failure." Nishiwaki F, Matsumura Y, Morita N, Kore-Eda S, Miyachi Y, Omoto M "Acrodermatitis continua of Hallopeau due to oral terbinafine." Clin Exp Dermatol 23 (1998): 64-728. Bonsmann G, Schiller M, Luger TA, Stander S "Terbinafine-induced subacute cutaneous lupus erythematosus."